Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

John Felder

Plastic Surgery Royal Oak, MI Medical Doctor

NPI 1336373828 CMS profile 1388397

3555 W 13 Mile Rd Ste N120, Div Surg Plastics Ste 202N, Royal Oak, MI 48073

Open in the dashboard

General payments

$125,613

266 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, John Felder of Royal Oak, MI is reported in the CMS Open Payments database as having received $125,613 across 266 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $25,142 50
2024 General $15,376 31
2023 General $36,823 57
2022 General $42,462 63
2021 General $1,575 25
2020 General $1,755 10
2019 General $2,480 30

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Felder
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to John Felder were reported at $25,142. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year John Felder Plastic Surgery median Middle half National median
2019 $2,480 $371 $122–$1,483 $163
2020 $1,755 $158 $52–$438 $114
2021 $1,575 $249 $87–$752 $132
2022 $42,462 $274 $102–$793 $149
2023 $36,823 $299 $113–$891 $160
2024 $15,376 $361 $124–$1,062 $164
2025 $25,142 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Integra LifeSciences Corporation $113,280 133 payments
  2. AxoGen $2,745 18 payments
  3. Kerecis Limited $1,675 10 payments
  4. Elite Orthopedics, LLC $961 1 payment
  5. Stryker Corporation $820 4 payments
  6. Acera Surgical, Inc. $630 11 payments
  7. PolyNovo North America LLC $510 10 payments
  8. Davol Inc. $481 6 payments
  9. DePuy Synthes Sales Inc. $475 4 payments
  10. KCI USA, Inc $403 6 payments
  11. Other $3,633 63 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $98,220 35 payments
  2. Food and Beverage $14,440 185 payments
  3. Travel and Lodging $11,992 45 payments
  4. Education $961 1 payment
Products named General payments · program years 2019–2025
  1. Integra Recon-Skin And Wound $80,610 87 payments
  2. Integra Recon-Skin And Wound $78,336 75 payments
  3. ADVANCED WOUND CARE $21,634 14 payments
  4. NEURAGEN $8,334 6 payments
  5. PRIMATRIX $8,236 66 payments
  6. CARPAL TUNNEL RELEASE SYSTEM $7,500 3 payments
  7. INTEGRA DERMAL REGENERATION TEMPLATE $6,043 57 payments
  8. Integra Recon-Skin And Wound $5,303 44 payments
  9. Avance Nerve Graft $2,212 14 payments
  10. AXOGUARD NERVE PROTECTOR $1,553 9 payments
  11. Other $27,423 260 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 58 billing codes

Paid by Medicare

$38,837

Medicare's payments for the services billed

Medicare patients

41

Average age 68

Services billed

161

16 women, 25 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 73%
Arthritis 46%
Diabetes 44%
Ischemic heart disease 44%
Cancer 32%
Depression 29%
Chronic kidney disease 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

266 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record